01 Jul, EOD - Indian

SENSEX 79476.19 (0.56)

Nifty 50 24141.95 (0.55)

Nifty Bank 52574.75 (0.44)

Nifty IT 36869.2 (1.97)

Nifty Midcap 100 56292.5 (1.00)

Nifty Next 50 72197.25 (0.94)

Nifty Pharma 19758.25 (0.14)

Nifty Smallcap 100 18593.65 (1.51)

01 Jul, EOD - Global

NIKKEI 225 39631.06 (0.12)

HANG SENG 17718.61 (0.01)

DOW JONES 39261.88 (0.37)

S&P 5456.21 (-0.08)

Login/Signup

Hot Pursuit News

You are Here : Home > Markets > News > Hot Pursuit News

(29 Jun 2024, 10:08)

Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam

Orchid Pharma said that it has partnered with Cipla to ensure widespread and rapid distribution of the company’s new drug- Cefepime-Enmetazobactam across India.

Cefepime-Enmetazobactam has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) indications.

"The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in the fight against AMR, a growing global health issue,” Orchid Pharma said in a statement.

The partnership between Orchid Pharma and Cipla combines Orchid's innovative drug development capabilities with Cipla's extensive distribution network and market presence. This collaboration aims to ensure that this life-saving medication reaches healthcare providers across India as quickly and efficiently as possible.

Manish Dhanuka, managing director Orchid Pharma said: “With increasin...

More News